Structural and biochemical characterization of inhibitor-1α

被引:7
|
作者
Huang, Hsien-Bin [1 ]
Chen, Yi-Chen
Lee, Ting-Ting
Huang, Yi-Choang
Liu, Hsin-Tzu
Liu, Chen-Kuang
Tsay, Huey-Jen
Lin, Ta-Hsien
机构
[1] Natl Chung Cheng Univ, Inst Mol Biol, Chiayi 621, Taiwan
[2] Tzu Chi Univ, Inst Med Sci, Hualien 970, Taiwan
[3] Tzu Chi Univ, Div Biochem, Hualien 970, Taiwan
[4] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan
[5] Natl Yang Ming Univ, Struct Biol Program, Taipei 112, Taiwan
[6] Natl Yang Ming Univ, Inst Neurosci, Taipei 112, Taiwan
[7] Buddhist Tzu Chi Gen Hosp, Dept Res, Hualien 970, Taiwan
[8] Vet Gen Hosp, Dept Med Res & Educ, Taipei 112, Taiwan
关键词
protein phosphatase-1; inhibitor-1; PKA; NMR; phosphorylation; dephosphorylation;
D O I
10.1002/prot.21438
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Inhibitor-.1 alpha is one of the isoforms of human protein phosphatase inhibitor-1. It is a product of alternative splicing of inhibitor-] gene and lacks 51 internal amino acids from residue 84 to 134 of inhibitor-L Here we have characterized the structural and biochemical properties of inhibitor-ii. Structural analysis of recombinant inhibitor-Ii by NMR spectroscopy revealed that inhibitor-ii adopts apredominantly random coil conformation. Excluding the region from residue 84 to 134 of inhibitor.1, the structural features of inhibitor-] and inhibitor-1 alpha are almost the same as each other. The IC50 value of inhibitor-1 alpha in inhibition of Protein phosphatase-1 (PPI) is comparable to that of inhibitor-1, indicating that inhibitor-1 alpha is a potent inhibitor of PPI when Thr-35 is phosphorylated by PKA. For phosphorylation by PKA and dephosphorylation by protein phosphatase-1, -2A, and -2B, the measured kinetic parameters of inhibitor-1 alpha very close to those of inhibitor-L Taken together, these results suggest that inhibitor-1 alpha preserves the structure of inhibitor- L the PPI inhibitory activity and the functional specificities toward phosphorylation by PKA and dephosphorylation by proteinphosphatase-1, -2A, and -2B.
引用
收藏
页码:779 / 788
页数:10
相关论文
共 50 条
  • [21] Is myosin phosphatase regulated in vivo by inhibitor-1?: Evidence from inhibitor-1 knockout mice
    Carr, AN
    Sutliff, RL
    Weber, CS
    Allen, PB
    Greengard, P
    de Lanerolle, P
    Kranias, EG
    Paul, RJ
    JOURNAL OF PHYSIOLOGY-LONDON, 2001, 534 (02): : 357 - 366
  • [22] Characterization of the interactions between inhibitor-1 and recombinant PP1 by NMR spectroscopy
    Chu-Ting Liang
    Yu-Shan Lin
    Yi-Choang Huang
    Hsien-Lu Huang
    Jia-Qian Yang
    Tsung-Hsien Wu
    Chi-Fon Chang
    Shing-Jong Huang
    Hsien-Bin Huang
    Ta-Hsien Lin
    Scientific Reports, 8
  • [23] Elucidation of the structural basis for the slow reactivity of thrombin with plasminogen activator inhibitor-1
    Rezaie, AR
    BIOCHEMISTRY, 1998, 37 (38) : 13138 - 13142
  • [24] ELUCIDATION OF STRUCTURAL REQUIREMENTS ON PLASMINOGEN-ACTIVATOR INHIBITOR-1 FOR BINDING TO HEPARIN
    EHRLICH, HJ
    GEBBINK, RK
    KEIJER, J
    PANNEKOEK, H
    JOURNAL OF BIOLOGICAL CHEMISTRY, 1992, 267 (16) : 11606 - 11611
  • [25] Characterization of the interactions between inhibitor-1 and recombinant PP1 by NMR spectroscopy
    Liang, Chu-Ting
    Lin, Yu-Shan
    Huang, Yi-Choang
    Huang, Hsien-Lu
    Yang, Jia-Qian
    Wu, Tsung-Hsien
    Chang, Chi-Fon
    Huang, Shing-Jong
    Huang, Hsien-Bin
    Lin, Ta-Hsien
    SCIENTIFIC REPORTS, 2018, 8
  • [26] Characterization of structural, biochemical, pharmacokinetic, and pharmacodynamic properties of the LSD1 inhibitor bomedemstat in preclinical models
    Jasmine, Sumer
    Mandl, Adel
    Krueger, Timothy E. G.
    Dalrymple, Susan L.
    Antony, Lizamma
    Dias, Jennifer
    Celatka, Cassandra A.
    Tapper, Amy E.
    Kleppe, Maria
    Kanayama, Mayuko
    Jing, Yuezhou
    Speranzini, Valentina
    Wang, Yuzhuo Z.
    Luo, Jun
    Trock, Bruce J.
    Denmeade, Samuel R.
    Carducci, Michael A.
    Mattevi, Andrea
    Rienhoff Jr, Hugh Y.
    Isaacs, John T.
    Brennen, W. Nathaniel
    PROSTATE, 2024, 84 (10): : 909 - 921
  • [27] The Purification and Characterization of Protein Phosphatase Inhibitor-1 from Rabbit Skeletal Muscle
    Cohen, Philip
    Nimmo, Gillian A.
    BIOCHEMICAL SOCIETY TRANSACTIONS, 1978, 6 : 17 - 20
  • [28] Polymerization of plasminogen activator inhibitor-1
    Zhou, A
    Faint, R
    Charlton, P
    Dafforn, TR
    Carrell, RW
    Lomas, DA
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (12) : 9115 - 9122
  • [29] Tiplaxtinin, a novel, orally efficacious inhibitor of plasminogen activator inhibitor-1: Design, synthesis, and preclinical characterization
    Elokdah, H
    Abou-Gharbia, M
    Hennan, JK
    McFarlane, G
    Mugford, CP
    Krishnamurthy, G
    Crandall, DL
    JOURNAL OF MEDICINAL CHEMISTRY, 2004, 47 (14) : 3491 - 3494
  • [30] DETERMINATION OF PA INHIBITOR-1 (PA INHIBITOR ACTIVITY AND PA INHIBITOR-1 ANTIGEN) IN PLASMA BEFORE AND AFTER VENOUS OCCLUSION
    JUHANVAGUE, I
    VALADIER, J
    ALESSI, MC
    ANSALDI, J
    AILLAUD, MF
    KRUITHOF, EKO
    THROMBOSIS AND HAEMOSTASIS, 1987, 58 (01) : 449 - 449